萤光原位杂交探针市场－全球产业规模、份额、趋势、机会和预测，按技术、类型（DNA、RNA）、应用、最终用途、地区和竞争细分，2020-2030 年

2024 年全球萤光原位杂交探针市场价值为 9.815 亿美元，预计在预测期内将实现令人印象深刻的成长，到 2030 年的复合年增长率为 6.45%。全球萤光原位杂交 (FISH) 探针市场正在快速扩张，这得益于肿瘤学、罕见疾病研究和细胞遗传学对高精度基因组诊断日益增长的需求。该市场涵盖 FISH 探针的开发、製造和商业化，FISH 探针是一种专门用于检测和定位完整细胞或组织样本内特定 DNA 或 RNA 序列的分子工具。

这些探针对于识别染色体异常、基因扩增、缺失或易位至关重要，因此在临床诊断和转化研究中都不可或缺。在肿瘤学中，FISH 探针通常用于支持标靶治疗决策，例如识别乳癌中的 HER2 基因扩增或肺癌中的 ALK 基因重排。它们在产前诊断、血液系统恶性肿瘤评估以及验证下一代定序平台的结果方面发挥着同样重要的作用。

市场成长也受到学术和製药研发领域采用率提高的推动，特别是随着精准医疗和基于生物标记的药物开发获得关注。此外，自动成像系统与人工智慧驱动解释的结合正在加快吞吐量并缩短分析时间，从而增强基于 FISH 的检测的临床实用性和商业可行性。

关键市场驱动因素

基因组研究的进展

主要市场挑战

竞争市场动态

主要市场趋势

扩大非侵入性产前检测（NIPT）的应用

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球萤光原位杂交探针市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依技术分类（Q FISH、FLOW FISH、其他）
  • 按类型（DNA、RNA（mRNA、miRNA、其他））
  • 按应用（癌症研究、遗传疾病、其他）
  • 依最终用途（研究、临床、伴随诊断）
  • 按地区
  • 按公司分类（2024）
• 产品市场图

第六章：北美萤光原位杂交探针市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲萤光原位杂交探针市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太地区萤光原位杂交探针市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第九章：南美洲萤光原位杂交探针市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲萤光原位杂交探针市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 科威特

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific Inc.
• PerkinElmer Health Sciences Inc
• Biodot Inc
• New Horizons Diagnostic Corp
• Merck KGaA
• Agilent Technologies, Inc.
• Abnova Corp.
• Genemed Biotechnologies Inc
• F. Hoffmann-La Roche Ltd
• Oxford Gene Technology Ltd

第 15 章：策略建议

第16章调查会社について・免责事项

Global Fluorescent In Situ Hybridization Probe Market was valued at USD 981.50 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2030. The Global Fluorescent In Situ Hybridization (FISH) Probe Market is undergoing rapid expansion, fueled by the rising demand for high-precision genomic diagnostics across oncology, rare disease research, and cytogenetics. This market encompasses the development, manufacturing, and commercialization of FISH probes specialized molecular tools designed to detect and localize specific DNA or RNA sequences within intact cells or tissue samples.

These probes are essential for identifying chromosomal abnormalities, gene amplifications, deletions, or translocations, making them indispensable in both clinical diagnostics and translational research. In oncology, FISH probes are routinely deployed to support targeted therapy decisions, such as identifying HER2 gene amplification in breast cancer or ALK gene rearrangements in lung cancer. Their role is equally critical in prenatal diagnostics, hematologic malignancy evaluation, and in validating results from next-generation sequencing platforms.

Market growth is also being driven by increased adoption in academic and pharmaceutical R&D, particularly as precision medicine and biomarker-based drug development gain traction. Further, the integration of automated imaging systems with AI-driven interpretation is accelerating throughput and reducing analysis time, enhancing the clinical utility and commercial viability of FISH-based assays.

Key Market Drivers

Advancements in Genomic Research

Advancements in genomic research have revolutionized our understanding of genetics, enabling breakthroughs in disease diagnosis, treatment, and prevention. One of the key technologies driving progress in this field is Fluorescent In Situ Hybridization (FISH), which allows researchers to visualize and locate specific DNA sequences within cells. As genomic research continues to evolve, so does the demand for FISH probes, making them a pivotal component of the Global FISH Probe Market. The sequencing of the human genome marked a monumental achievement in the field of genomics. It provided researchers with a comprehensive map of our genetic makeup, comprising over 20,000 protein-coding genes. However, understanding the functions and interactions of these genes requires tools like FISH probes to visualize their activity within cells. As genomics delves deeper into gene function, the demand for FISH probes increases. Genomic research has been instrumental in identifying genetic mutations that cause diseases. Whether it's rare genetic disorders or common ailments like cancer, researchers are increasingly using FISH probes to pinpoint specific mutations within the genome. This has significant implications for diagnosis, prognosis, and targeted therapies, driving the need for more advanced FISH probes. Advancements in genomics have ushered in the era of personalized medicine. By analyzing an individual's genetic profile, clinicians can tailor treatments to a patient's unique genetic makeup. FISH probes play a critical role in this process by helping identify specific genetic markers and abnormalities.

As personalized medicine gains traction, so does the demand for FISH probes that enable precise genetic analysis. Genomic research has revealed the genetic underpinnings of complex diseases like Alzheimer's, diabetes, and heart disease. Investigating these conditions often requires an in-depth understanding of genetic variations and gene expression patterns. FISH probes provide researchers with the tools to study these complexities at the cellular level, advancing our knowledge of disease mechanisms and potential therapeutic targets. The pharmaceutical industry heavily relies on genomic research to discover new drug targets and develop precision medicines. FISH probes are essential in validating potential drug targets by confirming the presence or absence of specific genetic markers in cellular models. This accelerates drug development and fuels the demand for FISH probes in research and development. Both academic research institutions and clinical laboratories benefit from advancements in genomics. Researchers in these settings use FISH probes for a wide range of applications, from studying basic biological processes to diagnosing genetic disorders. As research expands and diversifies, so does the market for FISH probes.

Key Market Challenges

Competitive Market Dynamics

Competition in the FISH Probe Market is fierce, with several major players and numerous smaller companies vying for market share. This competition can lead to price wars and pressure on profit margins. Differentiating products becomes crucial in this environment.

Key Market Trends

Expanding Applications in Non-Invasive Prenatal Testing (NIPT)

Non-invasive prenatal testing (NIPT) is revolutionizing prenatal care by allowing the detection of fetal chromosomal abnormalities through a simple blood test. FISH probes are becoming increasingly important in NIPT, enabling the identification of specific chromosomal disorders. The expansion of NIPT applications is expected to drive down the demand for FISH probes.

Key Market Players

• Thermo Fisher Scientific Inc.
• PerkinElmer Health Sciences Inc
• Biodot Inc
• New Horizons Diagnostic Corp
• Merck KGaA
• Agilent Technologies, Inc.
• Abnova Corp.
• Genemed Biotechnologies Inc
• F. Hoffmann-La Roche Ltd
• Oxford Gene Technology Ltd

Report Scope:

In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fluorescent In Situ Hybridization Probe Market, By Technology:

• Q FISH
• FLOW FISH
• Others

Fluorescent In Situ Hybridization Probe Market, By Type:

• DNA
• RNA
  • mRNA
  • miRNA
  • Others

Fluorescent In Situ Hybridization Probe Market, By Application:

• Cancer Research
• Genetic Diseases
• Others

Fluorescent In Situ Hybridization Probe Market, By End-Use:

• Research
• Clinical
• Companion Diagnostics

Fluorescent In Situ Hybridization Probe Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.

Available Customizations:

Global Fluorescent In Situ Hybridization Probe market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fluorescent In Situ Hybridization Probe Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Q FISH, FLOW FISH, Others)
  • 5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
  • 5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
  • 5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Product Market Map

6. North America Fluorescent In Situ Hybridization Probe Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-Use

7. Europe Fluorescent In Situ Hybridization Probe Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-Use
  • 7.3.2. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-Use
  • 7.3.3. France Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-Use

8. Asia-Pacific Fluorescent In Situ Hybridization Probe Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-Use
  • 8.3.2. Japan Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-Use
  • 8.3.3. India Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-Use
  • 8.3.4. Australia Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-Use
  • 8.3.5. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-Use

9. South America Fluorescent In Situ Hybridization Probe Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-Use
  • 9.3.2. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-Use
  • 9.3.3. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-Use

10. Middle East and Africa Fluorescent In Situ Hybridization Probe Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-Use
  • 10.3.3. UAE Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-Use
  • 10.3.4. Kuwait Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Technology
      • 10.3.4.2.2. By Type
      • 10.3.4.2.3. By Application
      • 10.3.4.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. PerkinElmer Health Sciences Inc
• 14.3. Biodot Inc
• 14.4. New Horizons Diagnostic Corp
• 14.5. Merck KGaA
• 14.6. Agilent Technologies, Inc.
• 14.7. Abnova Corp.
• 14.8. Genemed Biotechnologies Inc
• 14.9. F. Hoffmann-La Roche Ltd
• 14.10. Oxford Gene Technology Ltd

15. Strategic Recommendations

16. About Us & Disclaimer